Contract notice

Information

Published

Date of dispatch of this notice: 11/12/2020

Expire date: 20/01/2021

External Reference: 2020-220655

TED Reference: 2020/S 245-606587

Contract notice

[NoticeContract]

[Directive201424]

[Section1]: [Ca]

I.1)

[NameAddressContact]

Beaumont Hospital
N/A
Beaumont Road
Dublin
Beaumont
IE
[Contactpoint]: Margaret Fallon
[AddressPhone]: +353 17974182
[AddressEmail]: tendering@beaumont.ie
[Internets]:
Connolly Hospital Blanchardstown
Dublin
IE
[AddressEmail]: tendering@beaumont.ie
[Internets]:
Cavan and Monaghan Hospital
Cavan
IE
[AddressEmail]: tendering@beaumont.ie
[Internets]:
Our Lady of Lourdes Hospital
Drogheda, Co Louth
IE
[AddressEmail]: tendering@beaumont.ie
[Internets]:
Louth County Hospital
Dundalk
IE
[AddressEmail]: tendering@beaumont.ie
[Internets]:
I.2)

[JointProcurement]

[JointProcurementInvolves]
I.3)

[InfoTendering]

[AddressObtainDocs]:  
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=179767&B=ETENDERS_SIMPLE
[AddressFurtherinfo]
[AsContactsAbove]:  
[AddressSendTendersRequest]
[AddressSendTendersRequest]
[AddressToAbove]
I.4)

[CaType]

[MaintypePublicbody]
I.5)

[Mainactivity]

[MainactivHealth]

[Section2]: [Object]

II.1)

[QuantityScopeContract]

II.1.1)

[TitleContract]

The Supply of Intravenous Rituximab Pharmaceutical Products
[Fileref]:  2792
II.1.2)

[CpvMain]

33600000  - 
II.1.3)

[TypeContract]

[Supplies]
II.1.4)

[DescrShort]

The Contracting Authority intends to establish a single-party framework agreement with a suitably qualified economic operator for the supply of intravenous Rituximab pharmaceutical products and related services, as more fully described in the Invitation to Tender documents.
II.1.5)

[ValueMagnitudeEstimatedTotal]

[ValueExclVat]: 2500000.00  EUR
II.1.6)

[LotsInfo]

[DivisionLots]: [No]
II.2)

[Description]

II.2.2)

[CpvAdditional]

33600000  - 
II.2.3)

[PlacePerformance]

[MainsiteplaceWorksDelivery]:  
Dublin 9
II.2.4)

[DescrProcurement]

The Contracting Authority intends to establish a single-party framework agreement with a suitably qualified economic operator for the supply of intravenous Rituximab pharmaceutical products and related services, as more fully described in Appendix 1 of this Invitation to Tender document
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.6)

[ValueMagnitudeEstimated]

[ValueExclVat]: 2500000.00  EUR
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 60
[RenewalsSubject]: [No]
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [No]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]
II.2.14)

[InfoAdditional]

Please consult the Invitation to Tender documentation, available to download from www.etenders.gov.ie

[Section3]: [InfoLegal]

III.1)

[ConditionsParticip]

III.1.1)

[SituationPersonalIncl]

[InfoEvaluatingRequir]:  Please consult the Invitation to Tender documentation, available to download from www.etenders.gov.ie
III.1.2)

[EconomicFinancialStanding]

[InfoEvaluatingWethRequir]:  
Please consult the Invitation to Tender documentation, available to download from www.etenders.gov.ie
[MinStandardsRequired]:  
Please consult the Invitation to Tender documentation, available to download from www.etenders.gov.ie
III.1.3)

[TechnicalCapacity]

[InfoEvaluatingWethRequir]:  
Please consult the Invitation to Tender documentation, available to download from www.etenders.gov.ie
[MinStandardsRequired]:  
Please consult the Invitation to Tender documentation, available to download from www.etenders.gov.ie
III.2)

[ConditionsContract]

III.2.2)

[OtherConditions]

Please consult the Invitation to Tender documentation, available to download from www.etenders.gov.ie

[Section4]: [Procedure]

IV.1)

[Description]

IV.1.1)

[TypeProcedure]

[ProctypeOpen]
IV.1.3)

[FrameworkContractDpsInfo]

[NoticeInvolvesFramework]
[FrameworkSingle]
[FrameworkJustFour]:  In accordance with Article 33.1 of Directive 2014/24/EU, the maximum potential duration of this framework agreement (i.e., five years) is justified by reference to the implementation activities that will be required in order to successfully introduce the products in question to the Contracting Authority’s care pathways.
IV.1.8)

[GpaInfo]

[GpaCovered] : [No]
IV.2)

[InfoAdmin]

IV.2.2)

[LimitReceiptTendersReqPart]

[Date]:  20/01/2021
[Time]:  12:00
IV.2.4)

[LanguagesAllowed]

[Language_EN]
IV.2.6)

[MinTimeMaintain]

[DurationMonths] : 12  ([FromStatedDate])
IV.2.7)

[OpeningConditions]

[Date]:  20/01/2021
[Time]:  12:00

[Section6]: [InfoComplement]

VI.1)

[RecurrenceInfo]

[RecurrentProcurement]:  [No]
VI.2)

[InfoEworkflow]

[EinvoicingUsed]
[EpaymentUsed]
VI.4)

[AppealsProcedure]

VI.4.1)

[AppealsBody]

The High Court
Central Office of the High Court, Ground Floor, East Wing, The Four Courts, Inns Quay
Dublin 7
IE